Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)

NCT03156582 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03156582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03156582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
April 1, 2018
Enrollment
562 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma